22 May 2006
Final Results for the year ended 31 December 2005
Futura Medical plc (AIM: FUM), the pharmaceutical drug and medical device group that develops innovative products for sexual health, is pleased to announce its final results for the year ended 31 December 2005.
Operational Highlights
- CSD500 - regulatory dossier submitted to the relevant Notified Body and Competent Authority seeking marketing approval within the European Union
- FLD500 - Durex® exercises its option for global distribution and marketing rights
- MED2002 - in final stage of formal approval for worldwide development and commercialisation with a major global pharmaceutical group
Financial Highlights
- Pre-tax loss of £2.2 million (2004: £1.4 million)
- Cash balances of £1.8 million (2004: £3.7 million)
James Barder, Futura's Chief Executive, said: "2005 has been a year of solid progress and we look forward to an exciting and productive 12 months ahead".
The full results are available to download in PDF format.